Three committees share the responsibilities of the Institutional Review Board.
An Institutional Review Board (IRB) is a committee, including volunteers from Ohio State and its surrounding community, whose primary responsibility is to protect the rights and welfare of human research subjects. The authority conveyed to the IRBs includes decisions to approve, disapprove, require modifications, monitor, suspend and terminate research projects involving human subjects.
There are three internal IRBs at Ohio State that review, approve, and conduct periodic reviews of research involving human subjects (including data and biological materials obtained from human subjects) to ensure risks have been minimized and the potential for benefit has been maximized for human subjects participating in the research.
Member Rosters and Meeting Dates
Behavioral and Social Sciences IRB
Does not review investigator-initiated (funded or unfunded) research that:
- involve medical procedures, drugs, or devices, originating from a variety of disciplines including the arts, humanities, business, communication, education, music, nursing, political science, psychology, sociology, and social work
- FDA-regulated research
Member Rosters
Meeting Dates
Meetings will be held virtually until further notice from 11 a.m. – 1 p.m.
- April 19, 2024
- May 17, 2024
- June 21, 2024
- July 19, 2024
- August 16, 2024
- September 20, 2024
- October 18, 2024
- November 15, 2024
- December 20, 2024
- January 17, 2025
- February 21, 2025
- March 21, 2025
- April 18, 2025
- May 16, 2025
- June 20, 2025
Biomedical Sciences IRB
- reviews investigator-initiated (funded or unfunded) biomedical research, excluding cancer research
- does not review industry-initiated, industry-sponsored clinical trials
Member Rosters
Meeting Dates
Meetings will be held virtually until further notice at 2 p.m.
-
March 25, 2024
-
April 8, 2024
-
April 22, 2024
-
May 13, 2024
-
May 20, 2024 (3rd Monday due to Memorial Day Holiday)
-
June 10, 2024
-
June 24, 2024
Cancer IRB
- reviews investigator-initiated (funded or unfunded) research involving cancer surveillance, etiology, diagnosis, early detection, prevention, treatment, symptom control and survivorship studies, including quantitative, observational and interventional study designs
- does not review industry-initiated, industry-sponsored cancer clinical trials
Member Rosters
Meeting Dates
Meetings will be held virtually until further notice at 2 p.m.
- April 1, 2024
- April 15, 2024
- May 6, 2024
- May 20, 2024
- June 3, 2024
- June 17, 2024